![Hong Xia Sun](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Hong Xia Sun
Direttore/Membro del Consiglio presso Beijing Percutek Therapeutics, Inc.
Profilo
Hong Xia Sun currently works at Beijing Percutek Therapeutics, Inc., as Independent Director from 2022.
Posizioni attive di Hong Xia Sun
Società | Posizione | Inizio |
---|---|---|
Beijing Percutek Therapeutics, Inc.
![]() Beijing Percutek Therapeutics, Inc. Medical SpecialtiesHealth Technology Beijing Percutek Therapeutics, Inc. principally engages in the research, development, and application of innovative products and therapies in the field of vascular disease treatment. It researches, develops, produces, and sells medical device products in the fields of aorta, peripheral and coronary, as well as nerve intervention and access. The company was founded by Jian Zhou and Fan Yang on April 8, 2011 and is headquartered in Beijing, China. | Direttore/Membro del Consiglio | 30/05/2022 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
Beijing Percutek Therapeutics, Inc.
![]() Beijing Percutek Therapeutics, Inc. Medical SpecialtiesHealth Technology Beijing Percutek Therapeutics, Inc. principally engages in the research, development, and application of innovative products and therapies in the field of vascular disease treatment. It researches, develops, produces, and sells medical device products in the fields of aorta, peripheral and coronary, as well as nerve intervention and access. The company was founded by Jian Zhou and Fan Yang on April 8, 2011 and is headquartered in Beijing, China. | Health Technology |
- Borsa valori
- Insiders
- Hong Xia Sun